By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration and the Centers for Medicare and Medicaid Services are weighing the use of a parallel review process for medical devices that would speed up the process of making coverage decisions, and they have started a pilot program to try out the idea.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.